COVIDomics: The proteomic and metabolomic signatures of COVID-19

M Costanzo, M Caterino, R Fedele, A Cevenini… - International journal of …, 2022 - mdpi.com
Omics-based technologies have been largely adopted during this unprecedented global
COVID-19 pandemic, allowing the scientific community to perform research on a large scale …

Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19

C Bruzzone, R Conde, N Embade, JM Mato… - Frontiers in Molecular …, 2023 - frontiersin.org
COVID-19 currently represents one of the major health challenges worldwide. Albeit its
infectious character, with onset affectation mainly at the respiratory track, it is clear that the …

A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes

Y Chang, HJ Yoo, SJ Kim, K Lee, CM Lim, SB Hong… - Critical Care, 2023 - Springer
Background Acute respiratory distress syndrome (ARDS) is etiologically and clinically a
heterogeneous disease. Its diagnostic characteristics and subtype classification, and the …

Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19

S Druzak, E Iffrig, BR Roberts, T Zhang… - Nature …, 2023 - nature.com
The pathogenesis of multi-organ dysfunction associated with severe acute SARS-CoV-2
infection remains poorly understood. Endothelial damage and microvascular thrombosis …

Integrative plasma metabolic and lipidomic modelling of SARS-CoV-2 infection in relation to clinical severity and early mortality prediction

S Lodge, NG Lawler, N Gray, R Masuda… - International Journal of …, 2023 - mdpi.com
An integrative multi-modal metabolic phenotyping model was developed to assess the
systemic plasma sequelae of SARS-CoV-2 (rRT-PCR positive) induced COVID-19 disease …

Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19

M Kurano, K Okamoto, D Jubishi… - Clinical and …, 2022 - Wiley Online Library
Background A heterogeneous clinical phenotype is a characteristic of coronavirus disease
2019 (COVID‐19). Therefore, investigating biomarkers associated with disease severity is …

Medications modulating the acid sphingomyelinase/ceramide system and 28-day mortality among patients with SARS-CoV-2: an observational study

N Hoertel, K Rezaei, M Sánchez-Rico… - Pharmaceuticals, 2023 - mdpi.com
Prior evidence indicates the potential central role of the acid sphingomyelinase
(ASM)/ceramide system in the infection of cells with SARS-CoV-2. We conducted a …

Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility

OE Albóniga, E Moreno, J Martínez-Sanz, P Vizcarra… - Scientific Reports, 2023 - nature.com
The mechanisms driving SARS-CoV-2 susceptibility remain poorly understood, especially
the factors determining why unvaccinated individuals remain uninfected despite high-risk …

COVID-19 and cholesterol biosynthesis: Towards innovative decision support systems

E Kočar, S Katz, Ž Pušnik, P Bogovič, G Turel, C Skubic… - Iscience, 2023 - cell.com
With COVID-19 becoming endemic, there is a continuing need to find biomarkers
characterizing the disease and aiding in patient stratification. We studied the relation …

A platelet lipidomics signature in patients with COVID-19

L Goracci, E Petito, A Di Veroli, E Falcinelli… - Platelets, 2023 - Taylor & Francis
Ischemic cardiovascular and venous thromboembolic events are a frequent cause of death
in severe COVID-19 patients. Platelet activation plays a key role in these complications …